PPT Slide

N-acetylcysteine in ARDs

RCT of 42 pts with ARDs

• tx: 190mg/kg/day NAC (n=22) or placebo (n=20)
• mortality: 32% NAC vs. 25% placebo (NSF)
• 
  Domenighetti G, Suter PM et al. Treatment with N-acetylcysteine during acute respiratory distress syndrome: A randomized, double-blind, placebo-controlled clinical study. J of Crit Care 1997;12(4):177-182.

Previous slide

Next slide

Back to first slide

View graphic version